Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

8.60

-0.20 (-2.27%)

At close: Jul 20, 2026, 4:00 PM EDT

8.59

-0.01 (-0.12%)

After-hours: Jul 20, 2026, 7:34 PM EDT

Xeris Biopharma Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	314.85	291.85	203.07	163.91	110.25	49.59
Revenue Growth (YoY)	41.48%	43.72%	23.89%	48.68%	122.32%	142.67%
Cost of Revenue	44.42	42.57	36.83	28.65	22.63	13.32
Gross Profit	270.44	249.28	166.24	135.27	87.61	36.27
Selling, General & Admin	191.5	182.37	163.48	146.1	137.75	125.72
Depreciation & Amortization Expenses	10.84	10.84	10.84	10.84	10.84	0.55
Research & Development	32.2	31.17	25.56	22.34	20.97	25.16
Total Operating Expenses	234.54	224.38	199.88	179.28	169.55	151.43
Operating Income	35.9	24.9	-33.65	-44.01	-81.94	-115.16
Interest Income	4.77	4.74	5.32	4.75	2.58	0.31
Interest Expense	-28.66	-29.08	-30.49	-26.61	-14.1	-7.18
Other Non-Operating Income (Expense)	-	-	1.71	2.36	-2.62	-0.7
Total Non-Operating Income (Expense)	-23.89	-24.34	-23.46	-19.49	-14.14	-7.57
Pretax Income	12.01	0.55	-57.1	-63.5	-96.08	-122.73
Provision for Income Taxes	-	-	-2.27	-1.25	-1.42	-
Net Income	12.01	0.55	-54.84	-62.26	-94.66	-122.73
Net Income to Common	12.01	0.55	-54.84	-62.26	-94.66	-122.73
Shares Outstanding (Basic)	165	160	147	138	136	79
Shares Outstanding (Diluted)	174	173	147	138	136	79
Shares Change (YoY)	16.01%	17.69%	6.61%	1.51%	71.62%	85.32%
EPS (Basic)	0.07	0.00	-0.37	-0.45	-0.70	-1.55
EPS (Diluted)	0.06	0.00	-0.37	-0.45	-0.70	-1.55
Free Cash Flow	47.52	27.93	-37.85	-49.29	-103.42	-96.62
Free Cash Flow Growth	70.14%	-	-	-	-	-
Free Cash Flow Per Share	0.27	0.16	-0.26	-0.36	-0.76	-1.22
Gross Margin	85.89%	85.41%	81.86%	82.52%	79.47%	73.14%
Operating Margin	11.40%	8.53%	-16.57%	-26.85%	-74.32%	-232.22%
Profit Margin	3.81%	0.19%	-27.00%	-37.98%	-85.86%	-247.48%
FCF Margin	15.09%	9.57%	-18.64%	-30.07%	-93.80%	-194.84%
EBITDA	48.08	37.05	-21.58	-31.68	-69.7	-113.28
EBITDA Margin	15.27%	12.70%	-10.62%	-19.33%	-63.22%	-228.43%
EBIT	35.9	24.9	-33.65	-44.01	-81.94	-115.16
EBIT Margin	11.40%	8.53%	-16.57%	-26.85%	-74.32%	-232.22%
Effective Tax Rate	-	0.00%	3.97%	1.97%	1.48%	0.00%

SEC Filings: 10-K · 10-Q